LAVA-1207

· Lava Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LAVA-1207, covering 2025-08-01 to 2025-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer [Phase 1]

See pricing